Growth pill: Indian cos get high on patents

There are different ways of measuring innovation. The number of international patents that a country accumulates is one of them. India seems to be doing rather well on this count, with an increase in both the number of US patents issued and the number of patent applications.

India filed for 1,278 US patents in ’05, up by 36% over ’04, reversing a decline in ’04 when the number of patents filed declined by 15%. What’s more interesting is that the number of patents issued to India increased by 11% to 405, much higher than the growth rates of Japan, Taiwan, Canada, Germany and even China.

Indian companies have been stepping up their R&D activity and pharmaceuticals is one obvious sector, which has seen many companies being issued patents. Indian companies are making inroads into global markets, and a strong IPR pipeline will give them an edge.

Indian drug makers, which were granted patents in ’05 for the US market, include Ranbaxy Labs, Orchids Chemicals and Pharmaceuticals, Biocon, Sun Pharma, Lupin, Dr Reddy’s Labs, Wockhardt, Aurobindo and Cipla. Then there are others like Unilever’s India-based R&D operations.
read the rest of the news @ http://economictimes.indiatimes.com/articleshow/1474028.cms

Soruce : Economictimes.com